Show Notes
Secreted frizzled-related protein 2 is a protein that helps cancers grow by supporting the formation of new blood vessels, stopping cancer cells from dying, and weakening immune cells that should recognize and attack cancer cells. Dr. Nancy Klauber-DeMore is developing an antibody that blocks this protein. Early research suggests the antibody may halt the growth of triple-negative breast cancer.
Listen to the episode to hear Dr. Klauber-DeMore explain:
what secreted frizzled-related protein 2 does and why she thought blocking it might help treat breast cancer
why she’s focusing her work on triple-negative breast cancer
the next steps for the antibody she and her team have developed
More from Breastcancer.org Podcast
Actress Miranda McKeon was diagnosed with stage III breast cancer at age 19, just as she was starting her sophomore year of college. She talks about her experiences with diagnosis and treatment, as well as how she balanced presenting herself to her peers in a way that felt authentic when she was living an experience that was completely foreign to her.
Julia Maués didn’t decide to become an advocate, but her passion for patients learning science and scientists learning patient experiences propelled her to talk about her experiences.
Eleonora Teplinsky’s oncology practice has focused on people with breast cancer for more than a decade. Her new book, Beyond the Pink: Navigating Life, Health, and Breast Cancer, explains breast cancer risks, screening, diagnosis, and treatment, as well as topics that may not be discussed by all doctors.
Dr. Luba Perry is the founder and CEO of ReConstruct Bio, where she’s working to develop bioengineered living tissue implants made from a person’s own cells that then integrate with the body as living tissue. The first goal is to develop natural implants for breast reconstruction.
An advocate and communications expert with more than 20 years experience in international corporate marketing, Christina Wilhelm wrote It’s Breast Cancer, Now What? as a manual to help people navigate breast cancer treatment, return-to-work, and long-term follow-up care decisions.